| 20th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Mar 2026 12:00 pm |
RNS |
Lynavoy (linerixibat) approved by US FDA |
| 19th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 9th Mar 2026 3:00 pm |
RNS |
Board Committee Change |
| 9th Mar 2026 3:00 pm |
RNS |
Board Committee Change |
| 9th Mar 2026 7:00 am |
RNS |
GSK and Alfasigma agree global linerixibat rights |
| 9th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 6th Mar 2026 2:21 pm |
RNS |
Filing of GSK plc 2025 Annual Report on Form 20-F |
| 6th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 5th Mar 2026 10:00 am |
RNS |
GSK publishes Annual Report 2025 |
| 5th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 4th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 3rd Mar 2026 3:00 pm |
RNS |
GSK completes acquisition of RAPT Therapeutics |
| 3rd Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd Mar 2026 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 27th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 27th Feb 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Feb 2026 7:05 am |
RNS |
Linerixibat accepted for priority review in China |
| 26th Feb 2026 7:00 am |
RNS |
Bepirovirsen accepted for Japan regulatory review |
| 26th Feb 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Feb 2026 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 25th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 25th Feb 2026 7:00 am |
RNS |
GSK enters agreement to acquire 35Pharma |
